Finance
-
943UBS: Netflix is likely to stay on top of the video streaming world despite fierce competition (NFLX)
Netflix Netflix is well-positioned to lead the competition because it is a master of both content and technology, a UBS analyst said....
-
1.0KThe agency the White House just took over is about to feed us to loan sharks
Mick Mulvaney.REUTERS/Carlos Barria The Consumer Financial Protection Bureau is considering changing a rule so it’s easier for payday lenders to take more...
-
870CRYPTO INSIDER: The bloodbath continues
Angelo Merendino/Getty Images Welcome to Crypto Insider, Business Insider’s roundup of all the bitcoin and cryptocurrency news you need to know today....
-
1.1KThe hottest thing in cancer drug development is a takeover target again — here’s what you need to know about it (JUNO, CELG)
A nurse reaches for blood samples taken from a patient receiving a kind of immunotherapy known as CAR-T cell therapy at the...
-
886Ford is falling after guiding lower on earnings (F)
smjb / Creative Commons Ford is down 4.47% to $12.52 after the company guided 2018 earnings below expectations. The company said 2018...
-
844Here comes Goldman Sachs … (GS)
Goldman Sachs Chairman and CEO Blankfein speaks at the Bloomberg Global Business Forum in New YorkThomson Reuters Goldman Sachs is expected to...
-
992We crunched the numbers to find the one stock set to get the biggest boost from Trump tax reform
Reuters The corporate tax rate is being slashed to 20% from 35% under the Trump tax plan that took effect this year....
-
967Cryptocurrencies stabilise after ‘bloodbath’ — but bitcoin and ethereum are still falling
Markets Insider Cryptocurrency market stabilises after Tuesday’s “bloodbath.” But bitcoin, down 2%, and ethereum, down 5%, still suffering. Putin is proposing tighter...
-
975Walmart is hoping a simple packet could help curb opioid misuse (WMT)
Walmart Walmart is taking what could be a major step to curbing the opioid crisis. The company is supplying packets that can...
-
806Celgene is reportedly in talks to buy a $5.5 billion cancer drugmaker
Reuters Celgene is in talks to acquire Juno Therapeutics, The Wall Street Journal reported on Tuesday. If the deal materializes, it’d be...